Genetic research, conceptual image. DNA (deoxyribonucleic acid) autoradiogram in a petri dish.
Our Work

Latham Advises on Tricida’s US$125 Million Debt Facility

October 21, 2022
Firm advises on another leading structured life sciences debt facility.

Tricida, Inc. (Nasdaq: TCDA) announced that it has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets. The total amount of the debt facility is US$125 million of which US$100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.

Latham & Watkins LLP represented Hercules in the transaction with a team led by Bay Area partners Haim Zaltzman and Dan Van Fleet, and Bay Area associate Tony Noh. Advice was also provided on capital markets matters by New York partner Reza Mojtabaee-Zamani, with New York associates Eric Rice and Kevin Zhang; on regulatory matters by Washington, D.C. associate Chad Jennings; and on tax matters by Los Angeles partner Eric Cho.